JP3130235B2 - Nonwoven fabric, laminate thereof and method for producing nonwoven fabric - Google Patents

Nonwoven fabric, laminate thereof and method for producing nonwoven fabric

Info

Publication number
JP3130235B2
JP3130235B2 JP28968795A JP28968795A JP3130235B2 JP 3130235 B2 JP3130235 B2 JP 3130235B2 JP 28968795 A JP28968795 A JP 28968795A JP 28968795 A JP28968795 A JP 28968795A JP 3130235 B2 JP3130235 B2 JP 3130235B2
Authority
JP
Japan
Prior art keywords
nonwoven fabric
mite
weight
antibacterial
silver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP28968795A
Other languages
Japanese (ja)
Other versions
JPH08325915A (en
Inventor
博行 中上
裕行 三塚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idemitsu Petrochemical Co Ltd
Original Assignee
Idemitsu Petrochemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idemitsu Petrochemical Co Ltd filed Critical Idemitsu Petrochemical Co Ltd
Priority to JP28968795A priority Critical patent/JP3130235B2/en
Publication of JPH08325915A publication Critical patent/JPH08325915A/en
Application granted granted Critical
Publication of JP3130235B2 publication Critical patent/JP3130235B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nonwoven Fabrics (AREA)
  • Laminated Bodies (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、不織布、その積層体及
び不織布の製造方法に関し、寝具や床材等に利用でき
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a nonwoven fabric, a laminate thereof and a method for producing the nonwoven fabric, and can be used for bedding, flooring, and the like.

【0002】[0002]

【背景技術及び発明が解決しようとする課題】日本の梅
雨や夏期のような高温多湿下では、室内で雑菌、ダニ等
が発生しやすい状態となっている。また、このような時
期に限らず、近年、空調設備が完備してきたことによ
り、冬期であっても、雑菌、ダニ等の発生が見られるよ
うになってきている。
BACKGROUND OF THE INVENTION Under high temperature and high humidity conditions such as the rainy season and summer season in Japan, indoor germs and ticks are easily generated. Not only during such a period, but also in recent years, with the completion of air-conditioning equipment, even during the winter season, the occurrence of various bacteria, mites, and the like has been observed.

【0003】そして、布団、ベッド等の寝具や床下材な
どの床材において、このような雑菌、ダニ等の発生は特
に問題となる。例えば、寝具に潜むツメダニは、就寝
中、皮膚の柔らかいところを中心に痒みを伴う刺咬症の
原因となっており、ダニの生体、死骸、フン等は、アレ
ルギー喘息等の原因となっている。また、就寝中の発汗
による水分は、寝具中の湿度を高めて、雑菌の増殖を助
長し、これが寝具の悪臭の一原因ともなっている。
[0003] The occurrence of such germs, ticks and the like is particularly problematic in bedding such as futons and beds and flooring materials such as underfloor materials. For example, a claw mite lurking in bedding causes biting with itching, especially in soft skin, while sleeping, and living mites, dead bodies, dung, etc. cause allergic asthma and the like. In addition, moisture caused by perspiration during bedtime increases the humidity in the bedding and promotes the growth of various bacteria, which is one of the causes of the bad smell of the bedding.

【0004】寝具には、様々な柄や厚さの布が表面材と
して使用されているが、寝具メーカがこのような表面材
の全てに抗菌、防ダニ加工を施すのは経済的に困難であ
る。また、通常行われている薬剤の塗布による抗菌、防
ダニ加工の場合、洗濯や使用の際における擦れ等によっ
て、薬剤が脱落したりして効果の持続性に問題がある。
一方、不織布を布団の素材として用い、この不織布中に
薬剤を練り込んでおけば、良好な抗菌性と防ダニ性が期
待できる。
[0004] Bedding uses cloths of various patterns and thicknesses as surface materials, but it is economically difficult for a bedding maker to apply antibacterial and anti-mite treatment to all such surface materials. is there. In addition, in the case of antibacterial and mite-prevention processing by the usual application of a drug, there is a problem in persistence of the effect that the drug is dropped due to rubbing or the like during washing or use.
On the other hand, if a nonwoven fabric is used as a material for a futon and a drug is kneaded into the nonwoven fabric, good antibacterial properties and anti-mite properties can be expected.

【0005】しかし、抗菌性と防ダニ性のように多種の
機能を同時に持たせた不織布を得るため、何の制限もな
く、複数種の薬剤を樹脂原料と一緒に混練してフィラメ
ント(長繊維)として押し出し成形すると、薬剤の粒子
径が1〜数μmであっても、押し出し成形中に薬剤同士
が凝集して見掛け上、数十μmの凝集物になることがあ
る。押し出し成形中にこのような薬剤同士の凝集が起き
ると、径が細い連続長繊維を得る工程において、糸切れ
と呼ばれる繊維切れが発生して、製造上のトラブルや製
品不良の原因となる。
[0005] However, in order to obtain a nonwoven fabric having various functions such as antibacterial and mite-proof properties at the same time, there is no limitation. In the case of extrusion molding as (1), even if the particle size of the drug is 1 to several μm, the drugs may aggregate during extrusion molding to form apparently aggregates of several tens of μm. If such agglomeration of drugs occurs during extrusion molding, fiber breaks called thread breaks occur in the process of obtaining continuous filaments having a small diameter, which causes manufacturing troubles and product defects.

【0006】一方、床下素材にも防ダニ性や防虫性、抗
菌性などを付与したものが用いられており、薬剤を練り
込んだ熱可塑性樹脂の発泡体や、薬剤を練り込んだ繊維
を混合させたニードルパンチ式不織布、シート状素材に
薬剤を含浸させたものなどが知られている。
[0006] On the other hand, the underfloor material is also provided with mite-proofing, insect-proofing, antibacterial properties, etc., and is made by mixing a thermoplastic resin foam into which a drug is kneaded or a fiber into which a drug is kneaded. A needle-punched nonwoven fabric made by impregnating a drug into a sheet-like material and the like are known.

【0007】しかし、床下素材には一般に緩衝性等が要
求されるため高目付品が主流であり、含浸品は薬剤を多
く使用するのでコストがかかるとともに、前述した薬剤
同士の凝集を招くため耐久性に欠ける。また、練り込み
品も、発泡体の場合には素材が高目付な上に素材全体に
高価な薬剤を練り込む必要があるためコストがかかり、
ニードルパンチ式不織布の場合は、薬剤練り込み繊維を
得る工程において前述したような糸切れが生じやすく、
生産が困難であるとともにコストがかかる。
However, the underfloor material generally requires a buffering property or the like, so that a high-weight product is mainly used, and an impregnated product uses a large amount of chemicals, so that it is costly, and the above-mentioned cohesion of the chemicals is caused. Lack of sex. In addition, the kneaded product is expensive in the case of foam because the material is expensive and it is necessary to knead expensive chemicals throughout the material.
In the case of a needle-punch type nonwoven fabric, the yarn breakage as described above is likely to occur in the step of obtaining the fiber into which the drug is kneaded,
Production is difficult and costly.

【0008】そこで、本発明は、良好な抗菌性と防ダニ
性を同時に有し、耐久性に優れた不織布と、良好な抗菌
性と防ダニ性とを有し、安価に製造できる不織布の積層
体と、不織布を安定に製造できる製造方法を提供するこ
とを目的とする。
Accordingly, the present invention provides a laminate of a nonwoven fabric having both good antibacterial properties and mite resistance and having excellent durability, and a nonwoven fabric having good antibacterial properties and mite resistance and which can be produced at low cost. An object of the present invention is to provide a manufacturing method capable of stably manufacturing a body and a nonwoven fabric.

【0009】[0009]

【課題を解決するための手段及び作用】本発明の第1発
明に係る不織布は、銀系抗菌剤を0.3〜0.7wt%、合成ピ
レスロイド系防ダニ剤を0.2〜0.5wt%含有し、繊維径が
10〜50μmのポリオレフィンよりなることを特徴とす
る。
The nonwoven fabric according to the first invention of the present invention contains 0.3 to 0.7% by weight of a silver-based antibacterial agent and 0.2 to 0.5% by weight of a synthetic pyrethroid-based miticide, and has a fiber diameter of But
It is characterized by being composed of a polyolefin of 10 to 50 μm.

【0010】前記ポリオレフィンには、ポリプロピレ
ン、ポリエチレン等が含まれる。前記銀系抗菌剤の含有
量が、0.3wt%より少ない場合には抗菌効果が小さくな
る。また、0.7wt%より多く含有させると、同時に0.2〜
0.5wt%含有する合成ピレスロイド系防ダニ剤に影響さ
れて糸切れが発生して生産性が悪くなる。一方、合成ピ
レスロイド系防ダニ剤の含有量が0.2wt%より少ない
と、防ダニ効果が小さくなる。また、0.5wt%より多く
含有させると、同時に0.3〜0.7wt%含有する銀系抗菌剤
に影響されて糸切れが発生して生産性が低下する。
The polyolefin includes polypropylene, polyethylene and the like. When the content of the silver-based antibacterial agent is less than 0.3% by weight, the antibacterial effect is reduced. If more than 0.7 wt% is contained, at the same time 0.2-
Yarn breakage occurs due to the effect of the synthetic pyrethroid-based acaricide containing 0.5 wt%, resulting in poor productivity. On the other hand, when the content of the synthetic pyrethroid-based tick-controlling agent is less than 0.2 wt%, the tick-controlling effect is reduced. If the content is more than 0.5% by weight, the silver antibacterial agent simultaneously containing 0.3 to 0.7% by weight will cause the thread breakage and lower the productivity.

【0011】なお、銀系抗菌剤又は合成ピレスロイド系
防ダニ剤を単独で含有させる場合には、前記上限を超え
て含有させることも可能である。しかし、本発明のよう
に銀系抗菌剤と、合成ピレスロイド系防ダニ剤とを併有
させる場合、良好な抗菌性と防ダニ性を同時に得るに
は、他方の含量によって一方の含量が制限を受け、前記
含量とすることによって各薬剤の効果を充分に発揮させ
ることができるようになる。
When the silver-based antibacterial agent or the synthetic pyrethroid-based acaricide is contained alone, it may be contained in an amount exceeding the above upper limit. However, when a silver-based antibacterial agent and a synthetic pyrethroid-based acaricide are used together as in the present invention, in order to obtain good antibacterial properties and acaricide simultaneously, one content is restricted by the other content. In this case, the above-mentioned content makes it possible to sufficiently exert the effect of each drug.

【0012】また、抗菌剤として、前記銀系抗菌剤以外
の第四級アンモニウム化合物、チアゾリン系化合物等も
知られているが、耐熱性の点から銀系抗菌剤が好まし
い。また、防ダニ剤として、前記合成ピレスロイド系化
合物以外のカーバメイト系化合物、芳香族カルボン酸エ
ステル化合物、有機リン系化合物、天然ピレスロイド系
化合物等が知られているが、耐熱性を有し、抗菌剤と共
存させて安定な生産を可能とするには合成ピレスロイド
系化合物の使用が好ましい。
As antibacterial agents, quaternary ammonium compounds and thiazoline compounds other than the silver antibacterial agents are known, but silver antibacterial agents are preferred in view of heat resistance. As anti-mite agents, carbamate compounds other than the synthetic pyrethroid compounds, aromatic carboxylate compounds, organic phosphorus compounds, natural pyrethroid compounds, etc. are known, but have heat resistance and antibacterial agents Use of a synthetic pyrethroid compound is preferred to enable stable production in the presence of the compound.

【0013】前記合成ピレスロイド系防ダニ剤とは、除
虫菊中の有効成分であるピレトリンに類似した化合物
(ピレスロイドと呼ばれる菊酸エステル)であって、合
成されたものである。これに対して、天然ピレトリン
(除虫菊エキス)は、除虫菊乾花から有機溶媒で抽出
し、濃縮したものである。
The synthetic pyrethroid-based acaricide is a compound similar to pyrethrin, an active ingredient in pyrethrum, (a chrysanthemic ester called pyrethroid), which has been synthesized. On the other hand, natural pyrethrin (pyrethrum extract) is extracted from dried pyrethrum flowers with an organic solvent and concentrated.

【0014】本発明の第2発明に係る不織布は、第1発
明において、前記銀系抗菌剤が、リン酸ジルコニウム銀
化合物であることを特徴とする。前記リン酸ジルコニウ
ム銀化合物は、平均粒子径が1μm以下と、粒子径が小
さいため、糸切れを防止する上でも好ましい。
A nonwoven fabric according to a second aspect of the present invention is the nonwoven fabric according to the first aspect, wherein the silver-based antibacterial agent is a silver zirconium phosphate compound. The silver zirconium phosphate compound has an average particle diameter of 1 μm or less and has a small particle diameter, and is therefore preferable in preventing yarn breakage.

【0015】本発明の不織布は、連続長繊維(フィラメ
ント)からなるスパンボンド不織布と呼ばれるものであ
る。前記不織布の繊維径が10μmより小さいと、糸切れ
が発生して安定な生産ができなくなる。また、50μmよ
り大きいと、繊維径が太いために、感触が硬くなって不
織布の品質として好ましくない。
The nonwoven fabric of the present invention is a spunbonded nonwoven fabric made of continuous filaments (filaments). When the fiber diameter of the nonwoven fabric is smaller than 10 μm, thread breakage occurs and stable production cannot be performed. On the other hand, if it is larger than 50 μm, the fiber diameter is large and the feel becomes hard, which is not preferable as the quality of the nonwoven fabric.

【0016】本発明の第3発明に係る不織布の積層体
は、熱可塑性樹脂からなるシート状構造体の少なくとも
一方の面に、第1発明または第2発明の不織布が積層さ
れていることを特徴とする。なお、該不織布の目付につ
いては、特には制限はないが、目付が大きすぎるとコス
ト面で不利であり、あまり薄いと使用時の磨耗等で不織
布が破損する。これら両方を考慮して、不織布の目付は
15〜100g/m2であることが好ましく、更には15〜80g/m2
であることが好ましい。
The laminate of the nonwoven fabric according to the third invention of the present invention is characterized in that the nonwoven fabric of the first invention or the second invention is laminated on at least one surface of a sheet-like structure made of a thermoplastic resin. And The basis weight of the nonwoven fabric is not particularly limited. However, if the basis weight is too large, it is disadvantageous in terms of cost. If the basis weight is too thin, the nonwoven fabric is damaged due to abrasion during use. Considering both of these, the basis weight of the nonwoven fabric
Is preferably 15 to 100 / m 2, even 15 to 80 g / m 2
It is preferred that

【0017】シート状構造体の目付は特に限定しない
が、床下素材等の用途を考慮して、緩衝性をもたせるた
め、100g/m2以上であることが好ましい。熱可塑性樹脂
としては、発泡または紡糸可能なものであれば任意であ
り、用途や必要特性などを満たすように適宜選択でき
る。例えば、ポリプロピレン(PP)、ポリエチレン
(PE)、ポリスチレン(PS)、ポリエチレンテフタ
レート(PET)、ポリブチレンテレフタレート(PB
T)、塩化ビニル樹脂等が挙げられるが、好ましくはP
P、PE、PS、PETである。なお、発泡倍率、また
は繊維状成形体の繊維経や繊維長は必要に応じ適宜設定
する。
The basis weight of the sheet-like structure is not particularly limited, but it is preferably 100 g / m 2 or more in order to provide a cushioning property in consideration of uses such as underfloor materials. Any thermoplastic resin can be used as long as it can be foamed or spun, and can be appropriately selected so as to satisfy the intended use and required characteristics. For example, polypropylene (PP), polyethylene (PE), polystyrene (PS), polyethylene terephthalate (PET), polybutylene terephthalate (PB)
T), vinyl chloride resin and the like.
P, PE, PS, PET. The expansion ratio, the fiber diameter and the fiber length of the fibrous formed body are appropriately set as required.

【0018】シート状構造体と不織布との積層方法に
は、一般的な方法を適宜選択できる。例えば、接着剤に
よるラミネート、ヒートシールラミネート、押出ラミネ
ート、エンボスラミネート、リベット螺子やピンなどの
使用による積層等が挙げられる。
As a method of laminating the sheet-like structure and the nonwoven fabric, a general method can be appropriately selected. For example, lamination using an adhesive, heat seal lamination, extrusion lamination, emboss lamination, lamination using rivet screws or pins, and the like can be mentioned.

【0019】本発明の第4発明に係る不織布の積層体
は、第3発明において、前記シート状構造体は、熱可塑
性樹脂からなる発泡体及び熱可塑性樹脂からなるニード
ルパンチ式の不織布より選ばれた少なくとも一方を含む
ことを特徴とする。
The laminate of the nonwoven fabric according to the fourth invention of the present invention is the laminate of the third invention, wherein the sheet-like structure is selected from a foam made of a thermoplastic resin and a needle-punched nonwoven fabric made of a thermoplastic resin. And at least one of them.

【0020】シート状構造体を熱可塑性樹脂からなる発
泡体やニードルパンチ式の不織布を含むものとすること
により、抗菌性及び防ダニ性を有するとともに比較的高
目付な積層体が安価に得られるようになり、床下素材等
に有効に利用できる。
By forming the sheet-like structure including a foam made of a thermoplastic resin or a needle-punched non-woven fabric, a laminate having an antibacterial property and an anti-mite property and a relatively high weight can be obtained at a low cost. It can be effectively used for underfloor materials.

【0021】本発明の第5発明に係る不織布の製造方法
は、銀系抗菌剤を0.3〜0.7wt%、合成ピレスロイド系防
ダニ剤を0.2〜0.5wt%含有するポリオレフィン原料を混
練した後、このポリオレフィン原料から繊維径10〜50μ
mのフィラメントを作製し、前記フィラメントから不織
布を得ることを特徴とする。
In the method for producing a nonwoven fabric according to the fifth invention of the present invention, the method comprises kneading a polyolefin raw material containing 0.3 to 0.7% by weight of a silver-based antibacterial agent and 0.2 to 0.5% by weight of a synthetic pyrethroid-based acaricide. Fiber diameter 10-50μ from polyolefin raw material
m, and a nonwoven fabric is obtained from the filament.

【0022】不織布の製造方法は、通常、原料を溶
融、混練する溶融・混練工程、溶融した樹脂を紡糸ノ
ズルから押し出し、連続したフィラメント(長繊維)に
する紡糸工程、フィラメントをランダムに集積したシ
ート(ウェブ)をエンボスロールの間に通し、熱圧着さ
せて不織布を作製する熱圧着工程、不織布を必要サイ
ズに分割するスリット工程、スリットされた不織布を
巻き取る巻取り工程を有する。
The method for producing a nonwoven fabric generally includes a melting / kneading step of melting and kneading the raw materials, a spinning step of extruding the molten resin from a spinning nozzle to form continuous filaments (long fibers), and a sheet in which filaments are randomly accumulated. The method includes a thermocompression bonding step of passing the (web) between embossing rolls and thermocompression bonding to produce a nonwoven fabric, a slitting process of dividing the nonwoven fabric into a required size, and a winding process of winding the slit nonwoven fabric.

【0023】本発明に係る不織布の用途としては、使い
捨てシーツ、枕カバー等がある。布団、ベッド等の寝具
では、ダニや雑菌は、その内部に存在していることが多
い。従って、このような寝具を覆うように本発明の不織
布を使用するのが効果的である。例えば、病院等では、
シーツ、枕カバー等が毎日クリーニングされて繰り返し
使用されているが、本不織布は安価であるため、クリー
ニングを考慮すると使い捨ての方が経済的であり、かつ
抗菌性と防ダニ性を有しているため、非常に衛生的であ
る。
The use of the nonwoven fabric according to the present invention includes disposable sheets, pillow covers and the like. In beddings such as futons and beds, mites and various germs are often present inside. Therefore, it is effective to use the nonwoven fabric of the present invention so as to cover such bedding. For example, in hospitals,
Sheets, pillowcases, etc. are cleaned daily and used repeatedly, but since this nonwoven fabric is inexpensive, disposable is more economical in consideration of cleaning, and has antibacterial properties and anti-mite properties Because it is very hygienic.

【0024】[0024]

【実施例】【Example】

〔実施例1〕ポリオレフィンであるポリプロピレン(M
I=50)、銀系抗菌剤であるリン酸ジルコニウム銀化合
物及び防ダニ剤である合成ピレスロイド系化合物を原料
とし、全原料に対して銀系抗菌剤が0.3wt%、防ダニ剤
が0.2wt%となるように配合する。ここでは、予めポリ
プロピレン(MI=50)中に含有量が10wt%となるよう
に各薬剤が添加されたマスターバッチを作製しておき、
これらを使用して前記配合量に調整した。
[Example 1] Polyolefin, polypropylene (M
I = 50), using a silver zirconium phosphate compound as a silver-based antibacterial agent and a synthetic pyrethroid-based compound as an acaricide, with 0.3% by weight of silver-based antibacterial and 0.2wt. %. Here, a master batch was prepared in which each agent was added to polypropylene (MI = 50) so that the content was 10 wt%,
These were used to adjust the blending amount.

【0025】この配合された原料を押出機に投入し、樹
脂温度220℃で溶融、混練した後、溶融した樹脂をダイ
(200ホール)から押し出し、高速エアーで延伸、細化
して連続したフィラメント(長繊維)を作った。次に、
前記フィラメントをランダムに集積してシート(ウェ
ブ)とした後、引き続き、前記シートをエンボスパター
ンの形成されたロールと、表面の平滑なロールとの間に
通し、140℃で熱エンボスして不織布を作製した。
The compounded raw material is put into an extruder, melted and kneaded at a resin temperature of 220 ° C., and the melted resin is extruded from a die (200 holes), stretched and thinned with high-speed air to form a continuous filament ( Long fiber). next,
After the filaments are randomly accumulated to form a sheet (web), the sheet is subsequently passed between a roll having an embossed pattern and a roll having a smooth surface, and hot-embossed at 140 ° C. to form a nonwoven fabric. Produced.

【0026】次に、前記不織布を必要サイズにスリット
した後、スリットされた不織布を巻き取って本実施例の
連続長繊維不織布を製造した。この不織布は、その繊維
径が22.4μm、平均目付が50g/m2 であった。
Next, after slitting the nonwoven fabric to a required size, the slit nonwoven fabric was wound up to produce a continuous long-fiber nonwoven fabric of this example. This nonwoven fabric had a fiber diameter of 22.4 μm and an average basis weight of 50 g / m 2 .

【0027】本実施例について、不織布製造時の生産安
定性、不織布の抗菌性及び防ダニ性を評価した。前記生
産安定性の評価は、下記生産安定指数(γ)を測定する
ことにより行った。即ち、6時間の連続生産を行い、糸
切れの起きる回数を測定した。繰り返し数を3とし、そ
の平均値をとった。この指数が3以下のとき、糸切れの
発生が殆どなく、安定な生産が可能になる。
For this example, the production stability during the production of the nonwoven fabric, the antibacterial properties of the nonwoven fabric and the anti-mite properties were evaluated. The evaluation of the production stability was performed by measuring the following production stability index (γ). That is, continuous production was performed for 6 hours, and the number of times of yarn breakage was measured. The number of repetitions was set to 3, and the average was taken. When this index is 3 or less, there is almost no occurrence of yarn breakage, and stable production is possible.

【0028】[0028]

【数1】 (Equation 1)

【0029】前記不織布の抗菌性の評価は、シェイクフ
ラスコ法(繊維製品衛生加工協議会)に基づき減菌率を
測定することにより行った。即ち、不織布0.5gを細か
く切り、界面活性剤(Tween80 、商品名)を0.1%添加
したリン酸緩衝液15mlに入れ、更に黄色ブドウ球菌を加
えて振とうし、1時間後の生菌数を測定する。減菌率
は、下記式より求める。
The antibacterial properties of the nonwoven fabric were evaluated by measuring the sterilization rate based on the shake flask method (Fiber Sanitary Processing Council). That is, 0.5 g of the nonwoven fabric was finely cut, put into 15 ml of a phosphate buffer solution containing 0.1% of a surfactant (Tween 80, trade name), further added with Staphylococcus aureus and shaked, and the viable cell count after 1 hour was counted. Measure. The sterilization rate is determined by the following equation.

【0030】[0030]

【数2】 (Equation 2)

【0031】前記不織布の防ダニ性の評価は、ダニ忌避
率を測定することにより行った。即ち、プラスチックシ
ャーレ(直径4cm、高さ0.6cm)を粘着シート上に置
き、その周囲に6個の同一のシャーレを中央のシャーレ
と縁が接触するように置く。その中心部のシャーレに生
存ダニ数として約3000個体投入してダニ培地を作り、ダ
ニを入れたシャーレの周囲6個のシャーレには、直径4
cmに切り抜いた、薬剤を含有する不織布と、薬剤を含有
しない不織布とを交互に入れ、各試料上にダニの入って
いない粉末飼料0.05gを置く。これを食品保存用プラス
チック製容器(27×13×9cm)に粘着シートごと入れ、
飽和食塩水を入れて蓋をして、この容器内の湿度を約75
%に保つ。次に、この容器を25±1℃に保たれた恒温器
内に入れ、1昼夜飼育する。翌日、ダニを回収した後、
下記式に当てはめて忌避率を求める。なお、試験のばら
つきを考慮して、3回繰り返して行った。
The evaluation of the anti-mite property of the nonwoven fabric was carried out by measuring the rate of mites repelling. That is, a plastic petri dish (4 cm in diameter, 0.6 cm in height) is placed on an adhesive sheet, and six identical petri dishes are placed around the sheet so that the edge of the petri dish is in contact with the center petri dish. Approximately 3000 surviving mites were put into the petri dish at the center of the petri dish, and a mite culture medium was prepared.
A nonwoven fabric containing a drug and a nonwoven fabric containing no drug cut into cm are alternately placed, and 0.05 g of a powder feed free of mites is placed on each sample. Put this in a plastic container for food preservation (27 x 13 x 9 cm) together with the adhesive sheet,
Cover with saturated saline and cover the container with humidity of about 75
Keep at%. Next, the container is placed in a thermostat kept at 25 ± 1 ° C. and bred for 24 hours a day. The next day, after collecting the mites,
Apply the following formula to determine the repellent rate. The test was repeated three times in consideration of test variations.

【0032】[0032]

【数3】 (Equation 3)

【0033】〔実施例2〜4〕実施例1における抗菌剤
添加量及び防ダニ剤添加量を表1の通り変更し、実施例
1と同様にして各実施例の不織布を得た。各実施例の不
織布についても、実施例1と同様にして、不織布製造時
の生産安定性、不織布の抗菌性及び防ダニ性を評価し
た。それらの結果を表1に示す。
[Examples 2 to 4] The nonwoven fabrics of the respective examples were obtained in the same manner as in Example 1 except that the amount of the antibacterial agent and the amount of the anti-mite agent added in Example 1 were changed as shown in Table 1. In the same manner as in Example 1, the production stability of the nonwoven fabric of each of the examples and the antibacterial and mite-proof properties of the nonwoven fabric were evaluated. Table 1 shows the results.

【0034】〔比較例1〜4〕実施例1における抗菌剤
添加量及び防ダニ剤添加量を表2の通り変更し、実施例
1と同様にして各比較例の不織布を得た。
Comparative Examples 1 to 4 Non-woven fabrics of Comparative Examples were obtained in the same manner as in Example 1 except that the amount of the antibacterial agent and the amount of the acaricide added in Example 1 were changed as shown in Table 2.

【0035】〔比較例5,6〕実施例1における防ダニ
剤を芳香族カルボン酸エステル化合物に変更し、抗菌剤
添加量及び防ダニ剤添加量を表2の通りとして、実施例
1と同様にして各比較例の不織布を得た。上記比較例1
〜6の不織布についても、実施例1と同様にして、不織
布製造時の生産安定性、不織布の抗菌性及び防ダニ性を
評価した。それらの結果を表2に示す。
[Comparative Examples 5 and 6] The same as in Example 1 except that the anti-mite agent in Example 1 was changed to an aromatic carboxylic acid ester compound, and the amounts of the antibacterial agent and the anti-mite agent were as shown in Table 2. Thus, nonwoven fabrics of the respective comparative examples were obtained. Comparative Example 1 above
In the same manner as in Example 1, the nonwoven fabrics Nos. 6 to 6 were evaluated for the production stability during the production of the nonwoven fabric, the antibacterial property of the nonwoven fabric, and the anti-mite property. Table 2 shows the results.

【0036】[0036]

【表1】 [Table 1]

【0037】[0037]

【表2】 [Table 2]

【0038】表1より、本実施例に係る不織布は、銀系
抗菌剤を0.3〜0.7wt%、合成ピレスロイド系防ダニ剤を
0.2〜0.5wt%含有し、繊維径が22.4μmのポリオレフィ
ンよりなるため、抗菌性及び防ダニ性のいずれについて
も良好であることがわかる。
As shown in Table 1, the nonwoven fabric according to this embodiment contains 0.3 to 0.7% by weight of a silver-based antibacterial agent and a synthetic pyrethroid-based tick-proofing agent.
Since it contains 0.2 to 0.5 wt% and is made of polyolefin having a fiber diameter of 22.4 μm, it can be seen that both the antibacterial property and the anti-mite property are good.

【0039】また、本実施例に係る不織布の製造方法に
よれば、銀系抗菌剤を0.3〜0.7wt%、合成ピレスロイド
系防ダニ剤を0.2〜0.5wt%含有するポリオレフィン原料
を混練した後、このポリオレフィン原料から繊維径22.4
μmのフィラメントを作製し、前記フィラメントから不
織布を得るようにしているため、糸切れの発生がなく、
生産安定性が良好である。
Further, according to the method for producing a nonwoven fabric according to the present embodiment, after kneading a polyolefin raw material containing 0.3 to 0.7% by weight of a silver-based antibacterial agent and 0.2 to 0.5% by weight of a synthetic pyrethroid-based acaricide, Fiber diameter 22.4 from this polyolefin raw material
Since a non-woven fabric is obtained from the filament by producing a filament of μm, there is no occurrence of thread breakage,
Good production stability.

【0040】一方、表2より、比較例1によれば、防ダ
ニ剤の含有量は本発明の範囲内であるが、抗菌剤の含有
量が本発明の範囲より少ないため、抗菌性が不良であ
る。比較例2によれば、防ダニ剤の含有量は本発明の範
囲内であるが、抗菌剤の含有量が本発明の範囲より多い
ため、生産安定性が不良である。
On the other hand, from Table 2, according to Comparative Example 1, the content of the anti-mite agent is within the range of the present invention, but the antimicrobial content is less than the range of the present invention, so that the antibacterial property is poor. It is. According to Comparative Example 2, although the content of the anti-mite agent is within the range of the present invention, the production stability is poor because the content of the antibacterial agent is larger than the range of the present invention.

【0041】比較例3によれば、抗菌剤の含有量は本発
明の範囲内であるが、防ダニ剤の含有量が本発明の範囲
より少ないため、防ダニ性が不良である。比較例4によ
れば、抗菌剤の含有量は本発明の範囲内であるが、防ダ
ニ剤の含有量が本発明の範囲より多いため、生産安定性
が不良である。
According to Comparative Example 3, the content of the antibacterial agent is within the range of the present invention, but the content of the anti-mite agent is less than the range of the present invention, so that the anti-mite property is poor. According to Comparative Example 4, the content of the antibacterial agent is within the range of the present invention, but the content of the anti-mite agent is larger than the range of the present invention, so that the production stability is poor.

【0042】比較例5によれば、防ダニ剤として芳香族
カルボン酸エステル化合物を使用しているため、防ダニ
剤の含有量を本発明の範囲より多い0.8w%としても防ダ
ニ性が不良である。比較例6によれば、比較例5より防
ダニ剤の含有量を更に増やすと、防ダニ性は改善して
も、生産安定性が不良となる。
According to Comparative Example 5, since an aromatic carboxylic acid ester compound was used as an acaricide, even if the content of the acaricide was set to 0.8 w%, which is larger than the range of the present invention, the mite-proof property was poor. It is. According to Comparative Example 6, when the content of the tick-controlling agent is further increased as compared with Comparative Example 5, even if the tick-controlling property is improved, the production stability becomes poor.

【0043】〔実施例5〕実施例1における抗菌剤及び
防ダニ剤を各々0.7wt%、0.5wt%となるように配合し、実
施例1と同様にして目付20g/m2のポリプロピレン長繊維
不織布を得た。なお、抗菌剤と防ダニ剤とを合わせた薬
剤練り込み量は0.238g/m2であった。
Example 5 The antibacterial agent and the anti-mite agent of Example 1 were blended so as to be 0.7% by weight and 0.5% by weight, respectively, and a polypropylene filament having a basis weight of 20 g / m 2 was prepared in the same manner as in Example 1. A non-woven fabric was obtained. The combined amount of the antimicrobial agent and the anti-mite agent was 0.238 g / m 2 .

【0044】得られた不織布について、薬剤の蒸散率を
測定した。すなわち、サンプル1m2を25℃の恒温室内に
つるして 1年間放置し、放置前後の重量を測定して薬剤
の蒸散率を求めた。結果を表3に示す。
With respect to the obtained nonwoven fabric, the transpiration rate of the medicine was measured. That is, 1 m 2 of the sample was suspended in a constant temperature room at 25 ° C. and allowed to stand for one year, and the weight before and after the standing was measured to determine the evaporation rate of the drug. Table 3 shows the results.

【0045】〔比較例7〕実施例1における抗菌剤及び
防ダニ剤を配合しないで、実施例1と同様にして目付20
g/cm2のPP長繊維不織布を製造し、実施例5と同じ抗
菌剤及び防ダニ剤を各々0.7wt%、0.5wt%となるように含
浸させて本比較例の不織布を得た。なお、抗菌剤及び防
ダニ剤を合わせた薬剤塗布量は0.235g/m2であった。得
られた不織布について実施例5と同様に薬剤の蒸散率を
測定した。結果を表3に示す。
[Comparative Example 7] A weight per unit area was obtained in the same manner as in Example 1 except that the antibacterial agent and the anti-mite agent in Example 1 were not blended.
A PP long-fiber nonwoven fabric of g / cm 2 was produced, and impregnated with the same antibacterial agent and mite-proofing agent as in Example 5 so as to be 0.7 wt% and 0.5 wt%, respectively, to obtain a nonwoven fabric of this comparative example. The applied amount of the combination of the antibacterial agent and the anti-mite agent was 0.235 g / m 2 . About the obtained nonwoven fabric, the transpiration rate of the medicine was measured in the same manner as in Example 5. Table 3 shows the results.

【0046】[0046]

【表3】 [Table 3]

【0047】表3より、実施例5の不織布は薬剤が練り
込みにより添加されているため、薬剤を塗布により含浸
させた比較例7の不織布よりも薬剤の蒸散率が明らかに
少なく、耐久性に優れていることがわかる。
From Table 3, it can be seen that the non-woven fabric of Example 5 has a chemical vaporization rate lower than that of the non-woven fabric of Comparative Example 7 impregnated with the chemical, because the chemical is added by kneading, and the durability is improved. It turns out that it is excellent.

【0048】〔実施例6〕実施例1と同様にして目付30
g/m2のポリプロピレン長繊維不織布を製造した。なお、
抗菌剤と防ダニ剤とを合わせた薬剤練り込み量は0.15g/
m2であった。ニードルパンチ式不織布製造ライン中で、
このポリプロピレン不織布の上に目付量が70g/m2となる
ようにポリエステル繊維を積繊し、そのまま針で打ち込
むことにより、シート状構造体である目付量100g/m2
ポリエステルニードルパンチ式不織布とポリプロピレン
長繊維不織布との積層体を得た。
[Embodiment 6] Similar to the embodiment 1, the basis weight 30
g / m 2 polypropylene long-fiber nonwoven fabric was produced. In addition,
The combined amount of the antimicrobial agent and the anti-mite agent is 0.15 g /
It was m 2. In the needle punch type nonwoven fabric production line,
Polyester fiber is laid on this polypropylene non-woven fabric so that the weight per unit is 70 g / m 2, and the polyester fiber is punched with a needle as it is to form a polyester needle punched non-woven fabric with a weight per unit of 100 g / m 2 which is a sheet-like structure. A laminate with a polypropylene long fiber nonwoven fabric was obtained.

【0049】得られた積層体について、実施例1と同様
に抗菌性及び防ダニ性を試験した。この結果を表4に示
す。なお、薬剤を配合せずに製造したポリエステルニー
ドルパンチ式不織布とポリプロピレン長繊維不織布との
積層体の滅菌率及びダニ忌避率はともに0%であった。
The obtained laminate was tested for antibacterial and mite-proof properties in the same manner as in Example 1. Table 4 shows the results. In addition, both the sterilization rate and the mite repellency of the laminate of the polyester needle punched nonwoven fabric and the polypropylene long-fiber nonwoven fabric manufactured without adding the chemical were 0%.

【0050】〔実施例7〕目付量が200g/m2の架橋化発
泡ポリエチレンの片面に、実施例6と同様にして得た目
付30g/m2のポリプロピレン不織布を重ね合わせ、エンボ
スロールと表面が平滑なロールとの間に通し、140℃で熱
エンボスすることにより、シート状構造体であるこの発
泡体の片面に不織布をラミネートした積層体を得た。得
られた積層体について、実施例1と同様に抗菌性及び防
ダニ性を評価した。この結果を表4に示す。
Example 7 A nonwoven polypropylene fabric having a basis weight of 30 g / m 2 obtained in the same manner as in Example 6 was superposed on one side of crosslinked foamed polyethylene having a basis weight of 200 g / m 2 , The sheet was passed through a smooth roll and hot-embossed at 140 ° C. to obtain a laminate in which a nonwoven fabric was laminated on one side of the foam as a sheet-like structure. About the obtained laminated body, the antibacterial property and the mite-proof property were evaluated like Example 1. Table 4 shows the results.

【0051】〔比較例8〜11〕薬剤練り込み量を表4
の通りとし、目付量230g/m2の各比較例の架橋化発泡ポ
リエチレンを得た。なお、抗菌剤及び防ダニ剤は、実施
例1と同じものを使用した。各比較例の架橋化発泡ポリ
エチレンについて、実施例1と同様に滅菌率及びダニ忌
避率を調べた。これらの結果を表4に示す。
Comparative Examples 8 to 11
The crosslinked foamed polyethylene of each comparative example having a basis weight of 230 g / m 2 was obtained. The same antibacterial agent and anti-mite agent as in Example 1 were used. The sterilization rate and the mite repellent rate of the crosslinked foamed polyethylene of each comparative example were examined in the same manner as in Example 1. Table 4 shows the results.

【0052】[0052]

【表4】 [Table 4]

【0053】表4より、実施例6、7に係る積層体は、
銀系抗菌剤を0.3wt%、合成ピレスロイド系防ダニ剤を
0.2wt%含有し、繊維径が22.4μmのポリオレフィンよ
りなる不織布が片面に積層されているため、抗菌性及び
防ダニ性がいずれについても良好であることがわかる。
これにより、実施例1の不織布をシート状構造体の表面
に積層するだけで、シート構造体内部への雑菌やダニな
どの侵入を回避できるようになり、積層体全体に優れた
抗菌性及び防ダニ性を付与できることがわかる。また、
薬剤はポリプロピレン不織布のみに配合すればよいた
め、薬剤使用量が少なくて済み、経済的である。
According to Table 4, the laminates according to Examples 6 and 7 are:
0.3% by weight of silver-based antibacterial agent and synthetic pyrethroid-based miticide
Since the nonwoven fabric made of polyolefin having a fiber diameter of 22.4 μm and containing 0.2 wt% is laminated on one side, it can be seen that both antibacterial properties and antimite properties are good.
This makes it possible to avoid invasion of various bacteria and mites into the sheet structure only by laminating the nonwoven fabric of Example 1 on the surface of the sheet structure, and to provide excellent antibacterial properties and prevention of the entire laminate. It can be seen that tickness can be imparted. Also,
Since it is only necessary to mix the drug in the polypropylene non-woven fabric, the amount of the drug used is small, and it is economical.

【0054】比較例8〜10によれば、実施例7よりも
多量の薬剤が架橋化発泡ポリエチレン全体に練り込まれ
ているにも拘わらず、抗菌性及び防ダニ性がともに不良
である。実施例6の積層体のダニ忌避率及び滅菌率は比
較例2、4、6よりも若干低いが、それらは糸切れが多
く、業として生産ベースに乗るものではない。比較例1
1の積層体は、実施例7と同等なダニ忌避率であった
が、配合された薬剤使用量は実施例7の約17倍であり、
明らかにコスト高になる。
According to Comparative Examples 8 to 10, both the antibacterial property and the anti-mite property are poor, though a larger amount of the drug is kneaded into the whole crosslinked foamed polyethylene than in Example 7. Although the mite repellent rate and the sterilization rate of the laminate of Example 6 are slightly lower than those of Comparative Examples 2, 4, and 6, they have a large number of thread breaks and do not fit the production base as a business. Comparative Example 1
The laminate of No. 1 had a tick repellency equivalent to that of Example 7, but the compounded amount of the compound used was about 17 times that of Example 7,
Obviously costly.

【0055】[0055]

【発明の効果】本発明に係る不織布によれば、銀系抗菌
剤を0.3〜0.7wt%、合成ピレスロイド系防ダニ剤を0.2
〜0.5wt%含有し、繊維径が10〜50μmのポリオレフィ
ンよりなるため、良好な抗菌性と防ダニ性が同時に得ら
れる。本発明に係る不織布の積層体によれば、積層体全
体に対する良好な抗菌性及び防ダニ性を少ないコストで
確実に得られる。
According to the nonwoven fabric of the present invention, 0.3 to 0.7% by weight of the silver-based antibacterial agent and 0.2% of the synthetic pyrethroid-based tick preventive agent are used.
Since it is made of a polyolefin having a fiber diameter of 10 to 50 μm containing 0.5 to 0.5 wt%, good antibacterial properties and anti-mite properties can be obtained at the same time. ADVANTAGE OF THE INVENTION According to the laminated body of the nonwoven fabric which concerns on this invention, favorable antibacterial property and mite-proof property with respect to the whole laminated body can be obtained reliably at low cost.

【0056】また、本発明に係る不織布の製造方法によ
れば、銀系抗菌剤を0.3〜0.7wt%、合成ピレスロイド系
防ダニ剤を0.2〜0.5wt%含有するポリオレフィン原料を
混練した後、このポリオレフィン原料から繊維径10〜50
μmのフィラメントを作製し、前記フィラメントから不
織布を製造するため、糸切れの発生がなくなり、不織布
を安定に製造できる。
According to the method for producing a nonwoven fabric according to the present invention, a polyolefin material containing 0.3 to 0.7% by weight of a silver-based antibacterial agent and 0.2 to 0.5% by weight of a synthetic pyrethroid-based mite-proofing agent is kneaded. Fiber diameter 10-50 from polyolefin raw material
Since a non-woven fabric is manufactured from a filament having a thickness of μm and a non-woven fabric is manufactured from the filament, a non-woven fabric can be stably manufactured without occurrence of thread breakage.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 平7−54208(JP,A) 特開 平6−228823(JP,A) 特開 平6−2220(JP,A) 実開 平3−53595(JP,U) (58)調査した分野(Int.Cl.7,DB名) D04H 1/00 - 18/00 B32B 1/00 - 35/00 D01F 6/04 - 6/06 ──────────────────────────────────────────────────続 き Continuation of the front page (56) References JP-A-7-54208 (JP, A) JP-A-6-228823 (JP, A) JP-A-6-2220 (JP, A) 53595 (JP, U) (58) Fields investigated (Int. Cl. 7 , DB name) D04H 1/00-18/00 B32B 1/00-35/00 D01F 6/04-6/06

Claims (5)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 銀系抗菌剤を0.3〜0.7wt%、合成ピレス
ロイド系防ダニ剤を0.2〜0.5wt%含有し、繊維径が10〜
50μmのポリオレフィンよりなることを特徴とする不織
布。
1. A silver-based antibacterial agent containing 0.3 to 0.7% by weight, a synthetic pyrethroid-based miticide 0.2 to 0.5% by weight, and a fiber diameter of 10 to 10%.
A non-woven fabric comprising 50 μm polyolefin.
【請求項2】 前記銀系抗菌剤が、リン酸ジルコニウム
銀化合物であることを特徴とする請求項1記載の不織
布。
2. The nonwoven fabric according to claim 1, wherein said silver-based antibacterial agent is a silver zirconium phosphate compound.
【請求項3】 熱可塑性樹脂からなるシート状構造体の
少なくとも一方の面に、請求項1または請求項2に記載
した不織布が積層されていることを特徴とする不織布の
積層体。
3. A laminate of a nonwoven fabric, wherein the nonwoven fabric according to claim 1 or 2 is laminated on at least one surface of a sheet-like structure made of a thermoplastic resin.
【請求項4】 請求項3に記載した不織布の積層体にお
いて、前記シート状構造体は、熱可塑性樹脂からなる発
泡体及び熱可塑性樹脂からなるニードルパンチ式の不織
布より選ばれた少なくとも一方を含むことを特徴とする
不織布の積層体。
4. The nonwoven fabric laminate according to claim 3, wherein the sheet-like structure includes at least one selected from a foam made of a thermoplastic resin and a needle-punched nonwoven fabric made of a thermoplastic resin. A laminate of a nonwoven fabric, characterized in that:
【請求項5】 銀系抗菌剤を0.3〜0.7wt%、合成ピレス
ロイド系防ダニ剤を0.2〜0.5wt%含有するポリオレフィ
ン原料を混練した後、このポリオレフィン原料から繊維
径10〜50μmのフィラメントを作製し、前記フィラメン
トから不織布を得ることを特徴とする不織布の製造方
法。
5. After kneading a polyolefin material containing 0.3 to 0.7% by weight of a silver-based antibacterial agent and 0.2 to 0.5% by weight of a synthetic pyrethroid-based miticide, a filament having a fiber diameter of 10 to 50 μm is produced from the polyolefin material. And producing a non-woven fabric from the filament.
JP28968795A 1995-03-23 1995-11-08 Nonwoven fabric, laminate thereof and method for producing nonwoven fabric Expired - Fee Related JP3130235B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28968795A JP3130235B2 (en) 1995-03-23 1995-11-08 Nonwoven fabric, laminate thereof and method for producing nonwoven fabric

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-63919 1995-03-23
JP6391995 1995-03-23
JP28968795A JP3130235B2 (en) 1995-03-23 1995-11-08 Nonwoven fabric, laminate thereof and method for producing nonwoven fabric

Publications (2)

Publication Number Publication Date
JPH08325915A JPH08325915A (en) 1996-12-10
JP3130235B2 true JP3130235B2 (en) 2001-01-31

Family

ID=26405054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28968795A Expired - Fee Related JP3130235B2 (en) 1995-03-23 1995-11-08 Nonwoven fabric, laminate thereof and method for producing nonwoven fabric

Country Status (1)

Country Link
JP (1) JP3130235B2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9674698A (en) * 1997-10-02 1999-04-27 Synthetic Industries, Inc. Methods for controlling bacteria, mold, mildew and odors in conjunction with construction of buildings and related articles therefor
WO2001015712A1 (en) * 1999-09-01 2001-03-08 Shintofine Co., Ltd. Antiallergen compositions and method of inactivating allergen
KR20010091023A (en) * 2001-03-20 2001-10-22 안정오 Silver particle-containing nonwoven
KR100573030B1 (en) * 2002-05-28 2006-04-24 주식회사 삼흥 Silver Fiber and Manufacturing Method thereof
EP1814729A1 (en) * 2004-10-26 2007-08-08 Reemay, Inc. Composite fabric with controlled release of functional chemicals
JP4783707B2 (en) 2006-10-04 2011-09-28 クラレクラフレックス株式会社 Mask filter
US7520923B2 (en) * 2007-03-22 2009-04-21 Mvp Textiles & Apparel, Inc. Antimicrobial filtration article
WO2011016462A1 (en) 2009-08-07 2011-02-10 ユニ・チャーム株式会社 Face mask
CN102303415B (en) * 2011-05-26 2016-01-27 上海永利带业股份有限公司 The manufacture method of anti-acarid polyethylene light conveyer belt
JP2017065091A (en) * 2015-09-30 2017-04-06 日立化成テクノサービス株式会社 Laminated foam
JP2020092731A (en) * 2018-12-10 2020-06-18 南京優尼可国際貿易有限公司 Carpet

Also Published As

Publication number Publication date
JPH08325915A (en) 1996-12-10

Similar Documents

Publication Publication Date Title
JP3130235B2 (en) Nonwoven fabric, laminate thereof and method for producing nonwoven fabric
US8980772B2 (en) Barrier fabric
US20130251773A1 (en) Controlled Release Insect Repellent Materials
JP4854214B2 (en) Water absorbent non-woven laminate
WO2008086982A1 (en) Copper-containing polyester moulding compound, and production and use thereof
JP2003219947A (en) Mattress cover sheet with barrier effect
CN101343815B (en) Cocoon fibre fibrilia mixed packing core material
JPH08120551A (en) Mothproofing and antimicrobial felt and nonwoven fabric and their production
DE102007003662A1 (en) Antimicrobial polyester molding composition, useful e.g. for producing fibers, films or shaped articles, contains monovalent copper and aromatic, aliphatic and/or cycloaliphatic polyester(s)
WO2019161678A1 (en) Antibacterial bactericidal negative-ion releasing washable cushion and preparation method therefor
DE69821962T2 (en) METHOD FOR CONTROLLING HOUSE PITCHES AND BED MITCHES
JP3016141U (en) Antibacterial and tick-proof bedding
DE102007003649A1 (en) Polyester-based molding material containing divalent copper, used for production of blends, powder, molded parts, film, fabric or fibres with an antimicrobial action, e.g. for medical products
JP3558825B2 (en) Acaricide
JPH0436205A (en) Method for repelling sanitary insect pest
CN112796097A (en) Preparation method and application of silver ion long-acting bactericidal bedding
EP1830000A1 (en) Antimicrobial material consisting of polyacrylonitrile with metallic and non-metallic cations bound thereto
CN201267326Y (en) Antimicrobial anti-acarid bed mattress
JPH09117353A (en) Bedclothes containing filler having antibacterial antimycotic function
RU175256U1 (en) PILLOW
JP2725931B2 (en) Antibacterial and antifungal water supply mat
JPH059827A (en) Antibactericidal cellulose fiber
JP2020092731A (en) Carpet
JP2854185B2 (en) Fibers with anti-mite properties
CN201287488Y (en) Cocoon fibre fibrilia compound filling core material

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20001024

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20071117

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081117

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081117

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091117

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101117

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees